Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.750
+0.080 (3.00%)
At close: May 1, 2026, 4:00 PM EDT
2.740
-0.010 (-0.36%)
After-hours: May 1, 2026, 5:26 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $121.58 million as of May 1, 2026. Its market cap has increased by 26.85% in one year.
Market Cap
121.58M
Enterprise Value
108.67M
1-Year Change
26.85%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $121.58M, a decrease of -14.19%. That is a compound annual growth rate of -4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 121.58M | -25.87% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 131.51M |
| Immunic | 131.24M |
| Alpha Cognition | 129.56M |
| Kalaris Therapeutics | 125.54M |
| PepGen | 120.95M |
| Aardvark Therapeutics | 119.12M |
| Cardiff Oncology | 116.91M |
| Vivani Medical | 115.12M |